Global Insulin Pen Market

Insulin Pen Comprehensive Study by Type (Disposable cartridge Insulin Pens, Reusable cartridge Insulin Pens), Application (Hospital, Diabetes Clinics/ Centers, Home) Players and Region - Global Market Outlook to 2030

Insulin Pen Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 10.9%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Insulin Pen Market Scope
Insulin Pen is a pen used to inject insulin for the treatment of diabetes patients. The sleek design & compact size of insulin allows to easily deliver insulin anywhere by measuring & delivering from 0.5 to 80 units of insulin at a time. The maximum dose & the incremental amount vary depending upon the type of insulin pen being used. The insulin pen with its design allows accurate, simplified & convenient delivery. The insulin pen which are equipped & have auto shield needle may offer greater accuracy while injecting a dose. Insulin pens are easy to use and preferable for older people having diabetes. Insulin pen has ability to fine tune & deliver highly accurate doses with portable, discreet & convenient nature of pen. Insulin pen have small & thin needle size which reduces the pain & fear for injecting insulin. It is one of the time saving device with memory features as well to show when & how much the last dose was. As the insulin pens are equipped with pre-filled & replaceable needle features, preference for the insulin pen continue to remain high in global market. These pens may be reusable or disposable. Disposable pen contain a pre-filled insulin cartridge which is thrown away when the cartridge is empty and this cartridge easily disposable. The reusable pen contain a replaceable insulin cartridge. Once the cartridge is empty it may be discarded & put the new cartridge for use.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledBecton Dickinson (United States), Novo Nordisk (Denmark), B. Braun Melsungen (Germany), Spirit Healthcare (United Kingdom), Terumo Corporation (Japan), Ypsomed Holding AG (Switzerland), Dongbao Enterprise Group Co., Ltd. (China), Allison Medical (United States), UltiMed Inc. (United States), Shanghai Beipu Medical Co. Ltd. (China) and HTL-STREFA (Poland)
CAGR10.9%


"According to AMA, the Global Insulin Pen market is expected to see growth rate of 10.9% and may see market size of USD121.0 Million by 2030."

Key players are adopting numerous strategy to gain market attention and to increase their market share, this strategy can be listed as increasing product portfolio, making partnership to adopt certain technologies and acquiring small players to finish competition in the future. As well as investing money in R&D sector to make technical up-gradations in the product. Research Analyst at AMA estimates that European Players will contribute to the maximum growth of Global Insulin Pen market throughout the predicted period.

Becton Dickinson (United States), Novo Nordisk (Denmark), B. Braun Melsungen (Germany), Spirit Healthcare (United Kingdom), Terumo Corporation (Japan), Ypsomed Holding AG (Switzerland), Dongbao Enterprise Group Co., Ltd. (China), Allison Medical (United States), UltiMed Inc. (United States), Shanghai Beipu Medical Co. Ltd. (China) and HTL-STREFA (Poland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Owen Mumford (United States), Jiangsu Delfu medical device (China), Sanofi (France) and Eli Lilly (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Insulin Pen market by Type , by Application (Hospital, Diabetes Clinics/ Centers and Home) and Region with country level break-up.

On the basis of geography, the market of Insulin Pen has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
On 11th August 2020, Medtronic plc the global leader in medical technology announced the planned acquisition of privately-held Companion Medical, manufacturer of InPen — the only U.S. FDA-cleared smart insulin pen system paired with an integrated diabetes management app on the market. The addition of Companion Medical’s InPen to the Medtronic portfolio expands the company’s ability to serve people where they are in their diabetes journey and offer them a unique and expansive ecosystem of support — regardless of how insulin is delivered.
On 13th April 2021, BioCorp and Roche Diabetes Care France announced the launch of the Mallya smart insulin pen device in France. Developed by BioCorp, Mallya is an intelligent sensor for insulin injection pens that has CE mark approval in Europe. The platform is compatible with any disposable insulin pen. It enables reliable monitoring for doses selected for injection and it offers patients with diabetes better compliance with their treatment, according to the companies.
FDA's Center for Devices and Radiological Health (CDRH) is responsible for regulating firms who manufacture, repackage, relabel, and/or import medical devices. Food and Drug Administration (FDA) and World Health Organization (WHO) are providing the guidelines regarding the risk associated with medical device to ensure patient's safety and to check effectiveness of the devices.

Influencing Trend:
Reusable insulin pens i.e. replaceable cartridge and other infusion devices are becoming technologically advanced

Market Growth Drivers:
Easy to carry as portable and available in compact size, shows accuracy in measuring and delivering insulin, Ease of usability, Provision of data regarding last dose, Replaceable needles & cartridge increases lifespan of product and Low cost

Challenges:
strict government rules for new products developmen

Restraints:
customers are becoming more conscious regarding safety issues related to usage of infusion pen and

Opportunities:
Increasing arrival of diabetes in various age groups, Inclination of the customers towards Time saving device due to busy life and Emergence of affordable devices for such a common disease like diabetes

Key Target Audience
Manufacturer, Sub-component manufacturer, Channel partners, Industry Association, Governments and investment communities and Research organizations and associations

Report Objectives / Segmentation Covered

By Type
  • Disposable cartridge Insulin Pens
  • Reusable cartridge Insulin Pens
By Application
  • Hospital
  • Diabetes Clinics/ Centers
  • Home
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Easy to carry as portable and available in compact size
      • 3.2.2. Shows accuracy in measuring and delivering insulin
      • 3.2.3. Ease of usability
      • 3.2.4. Provision of data regarding last dose
      • 3.2.5. Replaceable needles & cartridge increases lifespan of product
      • 3.2.6. Low cost
    • 3.3. Market Challenges
      • 3.3.1. Strict government rules for new products developmen
    • 3.4. Market Trends
      • 3.4.1. Reusable insulin pens i.e. replaceable cartridge
      • 3.4.2. Other infusion devices are becoming technologically advanced
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Insulin Pen, by Type, Application and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Insulin Pen (Value)
      • 5.2.1. Global Insulin Pen by: Type (Value)
        • 5.2.1.1. Disposable cartridge Insulin Pens
        • 5.2.1.2. Reusable cartridge Insulin Pens
      • 5.2.2. Global Insulin Pen by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Diabetes Clinics/ Centers
        • 5.2.2.3. Home
      • 5.2.3. Global Insulin Pen Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Insulin Pen: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton Dickinson (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Novo Nordisk (Denmark)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. B. Braun Melsungen (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Spirit Healthcare (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Terumo Corporation (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Ypsomed Holding AG (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Dongbao Enterprise Group Co., Ltd. (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Allison Medical (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. UltiMed Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Shanghai Beipu Medical Co. Ltd. (China)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. HTL-STREFA (Poland)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Insulin Pen Sale, by Type, Application and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Insulin Pen (Value)
      • 7.2.1. Global Insulin Pen by: Type (Value)
        • 7.2.1.1. Disposable cartridge Insulin Pens
        • 7.2.1.2. Reusable cartridge Insulin Pens
      • 7.2.2. Global Insulin Pen by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Diabetes Clinics/ Centers
        • 7.2.2.3. Home
      • 7.2.3. Global Insulin Pen Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Insulin Pen: by Type(USD Million)
  • Table 2. Insulin Pen Disposable cartridge Insulin Pens , by Region USD Million (2018-2023)
  • Table 3. Insulin Pen Reusable cartridge Insulin Pens , by Region USD Million (2018-2023)
  • Table 4. Insulin Pen: by Application(USD Million)
  • Table 5. Insulin Pen Hospital , by Region USD Million (2018-2023)
  • Table 6. Insulin Pen Diabetes Clinics/ Centers , by Region USD Million (2018-2023)
  • Table 7. Insulin Pen Home , by Region USD Million (2018-2023)
  • Table 8. South America Insulin Pen, by Country USD Million (2018-2023)
  • Table 9. South America Insulin Pen, by Type USD Million (2018-2023)
  • Table 10. South America Insulin Pen, by Application USD Million (2018-2023)
  • Table 11. Brazil Insulin Pen, by Type USD Million (2018-2023)
  • Table 12. Brazil Insulin Pen, by Application USD Million (2018-2023)
  • Table 13. Argentina Insulin Pen, by Type USD Million (2018-2023)
  • Table 14. Argentina Insulin Pen, by Application USD Million (2018-2023)
  • Table 15. Rest of South America Insulin Pen, by Type USD Million (2018-2023)
  • Table 16. Rest of South America Insulin Pen, by Application USD Million (2018-2023)
  • Table 17. Asia Pacific Insulin Pen, by Country USD Million (2018-2023)
  • Table 18. Asia Pacific Insulin Pen, by Type USD Million (2018-2023)
  • Table 19. Asia Pacific Insulin Pen, by Application USD Million (2018-2023)
  • Table 20. China Insulin Pen, by Type USD Million (2018-2023)
  • Table 21. China Insulin Pen, by Application USD Million (2018-2023)
  • Table 22. Japan Insulin Pen, by Type USD Million (2018-2023)
  • Table 23. Japan Insulin Pen, by Application USD Million (2018-2023)
  • Table 24. India Insulin Pen, by Type USD Million (2018-2023)
  • Table 25. India Insulin Pen, by Application USD Million (2018-2023)
  • Table 26. South Korea Insulin Pen, by Type USD Million (2018-2023)
  • Table 27. South Korea Insulin Pen, by Application USD Million (2018-2023)
  • Table 28. Taiwan Insulin Pen, by Type USD Million (2018-2023)
  • Table 29. Taiwan Insulin Pen, by Application USD Million (2018-2023)
  • Table 30. Australia Insulin Pen, by Type USD Million (2018-2023)
  • Table 31. Australia Insulin Pen, by Application USD Million (2018-2023)
  • Table 32. Rest of Asia-Pacific Insulin Pen, by Type USD Million (2018-2023)
  • Table 33. Rest of Asia-Pacific Insulin Pen, by Application USD Million (2018-2023)
  • Table 34. Europe Insulin Pen, by Country USD Million (2018-2023)
  • Table 35. Europe Insulin Pen, by Type USD Million (2018-2023)
  • Table 36. Europe Insulin Pen, by Application USD Million (2018-2023)
  • Table 37. Germany Insulin Pen, by Type USD Million (2018-2023)
  • Table 38. Germany Insulin Pen, by Application USD Million (2018-2023)
  • Table 39. France Insulin Pen, by Type USD Million (2018-2023)
  • Table 40. France Insulin Pen, by Application USD Million (2018-2023)
  • Table 41. Italy Insulin Pen, by Type USD Million (2018-2023)
  • Table 42. Italy Insulin Pen, by Application USD Million (2018-2023)
  • Table 43. United Kingdom Insulin Pen, by Type USD Million (2018-2023)
  • Table 44. United Kingdom Insulin Pen, by Application USD Million (2018-2023)
  • Table 45. Netherlands Insulin Pen, by Type USD Million (2018-2023)
  • Table 46. Netherlands Insulin Pen, by Application USD Million (2018-2023)
  • Table 47. Rest of Europe Insulin Pen, by Type USD Million (2018-2023)
  • Table 48. Rest of Europe Insulin Pen, by Application USD Million (2018-2023)
  • Table 49. MEA Insulin Pen, by Country USD Million (2018-2023)
  • Table 50. MEA Insulin Pen, by Type USD Million (2018-2023)
  • Table 51. MEA Insulin Pen, by Application USD Million (2018-2023)
  • Table 52. Middle East Insulin Pen, by Type USD Million (2018-2023)
  • Table 53. Middle East Insulin Pen, by Application USD Million (2018-2023)
  • Table 54. Africa Insulin Pen, by Type USD Million (2018-2023)
  • Table 55. Africa Insulin Pen, by Application USD Million (2018-2023)
  • Table 56. North America Insulin Pen, by Country USD Million (2018-2023)
  • Table 57. North America Insulin Pen, by Type USD Million (2018-2023)
  • Table 58. North America Insulin Pen, by Application USD Million (2018-2023)
  • Table 59. United States Insulin Pen, by Type USD Million (2018-2023)
  • Table 60. United States Insulin Pen, by Application USD Million (2018-2023)
  • Table 61. Canada Insulin Pen, by Type USD Million (2018-2023)
  • Table 62. Canada Insulin Pen, by Application USD Million (2018-2023)
  • Table 63. Mexico Insulin Pen, by Type USD Million (2018-2023)
  • Table 64. Mexico Insulin Pen, by Application USD Million (2018-2023)
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Insulin Pen: by Type(USD Million)
  • Table 77. Insulin Pen Disposable cartridge Insulin Pens , by Region USD Million (2025-2030)
  • Table 78. Insulin Pen Reusable cartridge Insulin Pens , by Region USD Million (2025-2030)
  • Table 79. Insulin Pen: by Application(USD Million)
  • Table 80. Insulin Pen Hospital , by Region USD Million (2025-2030)
  • Table 81. Insulin Pen Diabetes Clinics/ Centers , by Region USD Million (2025-2030)
  • Table 82. Insulin Pen Home , by Region USD Million (2025-2030)
  • Table 83. South America Insulin Pen, by Country USD Million (2025-2030)
  • Table 84. South America Insulin Pen, by Type USD Million (2025-2030)
  • Table 85. South America Insulin Pen, by Application USD Million (2025-2030)
  • Table 86. Brazil Insulin Pen, by Type USD Million (2025-2030)
  • Table 87. Brazil Insulin Pen, by Application USD Million (2025-2030)
  • Table 88. Argentina Insulin Pen, by Type USD Million (2025-2030)
  • Table 89. Argentina Insulin Pen, by Application USD Million (2025-2030)
  • Table 90. Rest of South America Insulin Pen, by Type USD Million (2025-2030)
  • Table 91. Rest of South America Insulin Pen, by Application USD Million (2025-2030)
  • Table 92. Asia Pacific Insulin Pen, by Country USD Million (2025-2030)
  • Table 93. Asia Pacific Insulin Pen, by Type USD Million (2025-2030)
  • Table 94. Asia Pacific Insulin Pen, by Application USD Million (2025-2030)
  • Table 95. China Insulin Pen, by Type USD Million (2025-2030)
  • Table 96. China Insulin Pen, by Application USD Million (2025-2030)
  • Table 97. Japan Insulin Pen, by Type USD Million (2025-2030)
  • Table 98. Japan Insulin Pen, by Application USD Million (2025-2030)
  • Table 99. India Insulin Pen, by Type USD Million (2025-2030)
  • Table 100. India Insulin Pen, by Application USD Million (2025-2030)
  • Table 101. South Korea Insulin Pen, by Type USD Million (2025-2030)
  • Table 102. South Korea Insulin Pen, by Application USD Million (2025-2030)
  • Table 103. Taiwan Insulin Pen, by Type USD Million (2025-2030)
  • Table 104. Taiwan Insulin Pen, by Application USD Million (2025-2030)
  • Table 105. Australia Insulin Pen, by Type USD Million (2025-2030)
  • Table 106. Australia Insulin Pen, by Application USD Million (2025-2030)
  • Table 107. Rest of Asia-Pacific Insulin Pen, by Type USD Million (2025-2030)
  • Table 108. Rest of Asia-Pacific Insulin Pen, by Application USD Million (2025-2030)
  • Table 109. Europe Insulin Pen, by Country USD Million (2025-2030)
  • Table 110. Europe Insulin Pen, by Type USD Million (2025-2030)
  • Table 111. Europe Insulin Pen, by Application USD Million (2025-2030)
  • Table 112. Germany Insulin Pen, by Type USD Million (2025-2030)
  • Table 113. Germany Insulin Pen, by Application USD Million (2025-2030)
  • Table 114. France Insulin Pen, by Type USD Million (2025-2030)
  • Table 115. France Insulin Pen, by Application USD Million (2025-2030)
  • Table 116. Italy Insulin Pen, by Type USD Million (2025-2030)
  • Table 117. Italy Insulin Pen, by Application USD Million (2025-2030)
  • Table 118. United Kingdom Insulin Pen, by Type USD Million (2025-2030)
  • Table 119. United Kingdom Insulin Pen, by Application USD Million (2025-2030)
  • Table 120. Netherlands Insulin Pen, by Type USD Million (2025-2030)
  • Table 121. Netherlands Insulin Pen, by Application USD Million (2025-2030)
  • Table 122. Rest of Europe Insulin Pen, by Type USD Million (2025-2030)
  • Table 123. Rest of Europe Insulin Pen, by Application USD Million (2025-2030)
  • Table 124. MEA Insulin Pen, by Country USD Million (2025-2030)
  • Table 125. MEA Insulin Pen, by Type USD Million (2025-2030)
  • Table 126. MEA Insulin Pen, by Application USD Million (2025-2030)
  • Table 127. Middle East Insulin Pen, by Type USD Million (2025-2030)
  • Table 128. Middle East Insulin Pen, by Application USD Million (2025-2030)
  • Table 129. Africa Insulin Pen, by Type USD Million (2025-2030)
  • Table 130. Africa Insulin Pen, by Application USD Million (2025-2030)
  • Table 131. North America Insulin Pen, by Country USD Million (2025-2030)
  • Table 132. North America Insulin Pen, by Type USD Million (2025-2030)
  • Table 133. North America Insulin Pen, by Application USD Million (2025-2030)
  • Table 134. United States Insulin Pen, by Type USD Million (2025-2030)
  • Table 135. United States Insulin Pen, by Application USD Million (2025-2030)
  • Table 136. Canada Insulin Pen, by Type USD Million (2025-2030)
  • Table 137. Canada Insulin Pen, by Application USD Million (2025-2030)
  • Table 138. Mexico Insulin Pen, by Type USD Million (2025-2030)
  • Table 139. Mexico Insulin Pen, by Application USD Million (2025-2030)
  • Table 140. Research Programs/Design for This Report
  • Table 141. Key Data Information from Secondary Sources
  • Table 142. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Insulin Pen: by Type USD Million (2018-2023)
  • Figure 5. Global Insulin Pen: by Application USD Million (2018-2023)
  • Figure 6. South America Insulin Pen Share (%), by Country
  • Figure 7. Asia Pacific Insulin Pen Share (%), by Country
  • Figure 8. Europe Insulin Pen Share (%), by Country
  • Figure 9. MEA Insulin Pen Share (%), by Country
  • Figure 10. North America Insulin Pen Share (%), by Country
  • Figure 11. Global Insulin Pen share by Players 2023 (%)
  • Figure 12. Global Insulin Pen share by Players (Top 3) 2023(%)
  • Figure 13. Global Insulin Pen share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Becton Dickinson (United States) Revenue, Net Income and Gross profit
  • Figure 16. Becton Dickinson (United States) Revenue: by Geography 2023
  • Figure 17. Novo Nordisk (Denmark) Revenue, Net Income and Gross profit
  • Figure 18. Novo Nordisk (Denmark) Revenue: by Geography 2023
  • Figure 19. B. Braun Melsungen (Germany) Revenue, Net Income and Gross profit
  • Figure 20. B. Braun Melsungen (Germany) Revenue: by Geography 2023
  • Figure 21. Spirit Healthcare (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Spirit Healthcare (United Kingdom) Revenue: by Geography 2023
  • Figure 23. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 24. Terumo Corporation (Japan) Revenue: by Geography 2023
  • Figure 25. Ypsomed Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 26. Ypsomed Holding AG (Switzerland) Revenue: by Geography 2023
  • Figure 27. Dongbao Enterprise Group Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 28. Dongbao Enterprise Group Co., Ltd. (China) Revenue: by Geography 2023
  • Figure 29. Allison Medical (United States) Revenue, Net Income and Gross profit
  • Figure 30. Allison Medical (United States) Revenue: by Geography 2023
  • Figure 31. UltiMed Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. UltiMed Inc. (United States) Revenue: by Geography 2023
  • Figure 33. Shanghai Beipu Medical Co. Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 34. Shanghai Beipu Medical Co. Ltd. (China) Revenue: by Geography 2023
  • Figure 35. HTL-STREFA (Poland) Revenue, Net Income and Gross profit
  • Figure 36. HTL-STREFA (Poland) Revenue: by Geography 2023
  • Figure 37. Global Insulin Pen: by Type USD Million (2025-2030)
  • Figure 38. Global Insulin Pen: by Application USD Million (2025-2030)
  • Figure 39. South America Insulin Pen Share (%), by Country
  • Figure 40. Asia Pacific Insulin Pen Share (%), by Country
  • Figure 41. Europe Insulin Pen Share (%), by Country
  • Figure 42. MEA Insulin Pen Share (%), by Country
  • Figure 43. North America Insulin Pen Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Becton Dickinson (United States)
  • Novo Nordisk (Denmark)
  • B. Braun Melsungen (Germany)
  • Spirit Healthcare (United Kingdom)
  • Terumo Corporation (Japan)
  • Ypsomed Holding AG (Switzerland)
  • Dongbao Enterprise Group Co., Ltd. (China)
  • Allison Medical (United States)
  • UltiMed Inc. (United States)
  • Shanghai Beipu Medical Co. Ltd. (China)
  • HTL-STREFA (Poland)
Additional players considered in the study are as follows:
Owen Mumford (United States) , Jiangsu Delfu medical device (China) , Sanofi (France) , Eli Lilly (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 248 Pages 61 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Insulin Pen Market Quantitative research analysis
Global Insulin Pen Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Insulin Pen Market are by type [Disposable cartridge Insulin Pens and Reusable cartridge Insulin Pens], by end use application [Hospital, Diabetes Clinics/ Centers and Home].
The Insulin Pen Market is gaining popularity and expected to see strong valuation by 2030.
  • Easy to carry as portable and available in compact size
  • shows accuracy in measuring and delivering insulin
  • Ease of usability
  • Provision of data regarding last dose
  • Replaceable needles & cartridge increases lifespan of product
  • Low cost

Know More About Global Insulin Pen Market Report?

Have a Query? Click Here

Other Related Reports

Knee Reconstruction Devices Comprehensive Study by Type (Primary Implants Knee Reconstruction (Cement less, Cemented), Partial Implants Knee Reconstruction, Revision Implants Knee Reconstruction), Ap...
$ 3750
Medical Cyclotron Comprehensive Study by Type (Upto 15 MeV, 25 MeV-30 MeV, 35 MeV-60 MeV, More than 60 MeV), Application (Diagnostic and Treatment, Research and Development, Others), End-Users (Hospi...
$ 3450
Endotracheal Tubes Comprehensive Study by Type (Cuff, Uncuffed), Application (Laser Surgery, Head and Neck Surgery, Anesthesia, Others), End-Users (Hospital, Clinics, Ambulatory Surgical Centers), In...
$ 3450
Interference Screws Comprehensive Study by Type (Posterior Cruciate Ligament, Anterior Cruciate Ligament), Application (Shoulder, Foot/Ankle, Knee, Elbow, Hand/Wrist), Surgery (Primary Surgery, Revis...
$ 3450
Digital Wound Measurement Devices Comprehensive Study by Type (Contact Type , Non-Contact Type), Application (Hospitals , Clinics , Others), Device Type (3D Wound Measurement Devices, Laser-Assisted ...
$ 3650
Medical Laser Systems Comprehensive Study by Type (Diode Laser Systems, Solid State Laser Systems, Gas Lasers Systems, Dye Lasers Systems), Application (Aesthetic, Surgical, Ophthalmology, Others), E...
$ 3450